| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9831 |
| Human Intestinal Absorption | HIA+ | 0.9284 |
| Caco-2 Permeability | Caco2+ | 0.5352 |
| P-glycoprotein Substrate | Non-substrate | 0.8310 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9472 |
| Non-inhibitor | 0.9647 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.9425 |
| Distribution |
| Subcellular localization | Mitochondria | 0.8332 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8318 |
| CYP450 2D6 Substrate | Non-substrate | 0.9048 |
| CYP450 3A4 Substrate | Non-substrate | 0.7604 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.8780 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9246 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9494 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9127 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9711 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9711 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9393 |
| Non-inhibitor | 0.9861 |
| AMES Toxicity | Non AMES toxic | 0.9419 |
| Carcinogens | Carcinogens | 0.5900 |
| Fish Toxicity | High FHMT | 0.6147 |
| Tetrahymena Pyriformis Toxicity | Low TPT | 0.9599 |
| Honey Bee Toxicity | High HBT | 0.7123 |
| Biodegradation | Ready biodegradable | 0.9844 |
| Acute Oral Toxicity | III | 0.7463 |
| Carcinogenicity (Three-class) | Non-required | 0.6313 |